Literature DB >> 17703425

Serum antipneumococcal antibodies and pneumococcal colonization in adults with chronic obstructive pulmonary disease.

Richard Malley1, Marc Lipsitch, Debby Bogaert, Claudette M Thompson, Peter Hermans, A Claire Watkins, Sanjay Sethi, Timothy F Murphy.   

Abstract

Antibodies to pneumococcus are thought to represent the primary mechanism of naturally acquired resistance to colonization. Here, however, we show that, in patients with chronic obstructive pulmonary disease (COPD), resistance to pneumococcal colonization is not associated with higher concentrations of serum anti-capsular or -noncapsular antibodies. We compared preacquisition serum antibody concentrations to capsular antigens 6B, 7F, 14, 19F, and 23F from patients with COPD who did and did not acquire pneumococcal respiratory tree colonization over the course of 2 years. Colonized patients did not have lower anti-capsular antibody concentrations than control subjects who did not acquire pneumococcus. We found no difference in functional antibody concentrations between colonized patients and control subjects. Furthermore, colonized patients had significantly higher preacquisition concentration of antibody directed against the whole cell and pneumococcal surface protein A than control subjects. We thus conclude that, in adult patients with COPD, resistance to pneumococcal colonization is unlikely to be determined by higher serum antibody concentrations to pneumococcal antigens.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17703425     DOI: 10.1086/520937

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Phagocytic dysfunction of human alveolar macrophages and severity of chronic obstructive pulmonary disease.

Authors:  Charles S Berenson; Ragina L Kruzel; Ellana Eberhardt; Sanjay Sethi
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

2.  Impaired CD4+ and T-helper 17 cell memory response to Streptococcus pneumoniae is associated with elevated glucose and percent glycated hemoglobin A1c in Mexican Americans with type 2 diabetes mellitus.

Authors:  Perla J Martinez; Christine Mathews; Jeffrey K Actor; Shen-An Hwang; Eric L Brown; Heather K De Santiago; Susan P Fisher Hoch; Joseph B McCormick; Shaper Mirza
Journal:  Transl Res       Date:  2013-08-05       Impact factor: 7.012

3.  Impaired function of antibodies to pneumococcal surface protein A but not to capsular polysaccharide in Mexican American adults with type 2 diabetes mellitus.

Authors:  Christine E Mathews; Eric L Brown; Perla J Martinez; Upasana Bagaria; Moon H Nahm; Robert L Burton; Susan P Fisher-Hoch; Joseph B McCormick; Shaper Mirza
Journal:  Clin Vaccine Immunol       Date:  2012-07-03

4.  Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary disease.

Authors:  Mark T Dransfield; Sarah Harnden; Robert L Burton; Richard K Albert; William C Bailey; Richard Casaburi; John Connett; J Allen D Cooper; Gerard J Criner; Jeffrey L Curtis; Meilan K Han; Barry Make; Nathaniel Marchetti; Fernando J Martinez; Charlene McEvoy; Moon H Nahm; Dennis E Niewoehner; Janos Porszasz; John Reilly; Paul D Scanlon; Steven M Scharf; Frank C Sciurba; George R Washko; Prescott G Woodruff; Stephen C Lazarus
Journal:  Clin Infect Dis       Date:  2012-05-31       Impact factor: 9.079

5.  The changing epidemiology of pneumococcal pulmonary disease in the era of the heptavalent vaccine.

Authors:  Catherine A Lexau
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

Review 6.  Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development.

Authors:  Richard Malley
Journal:  J Mol Med (Berl)       Date:  2010-01-05       Impact factor: 4.599

7.  Protection against nasopharyngeal colonization by Streptococcus pneumoniae is mediated by antigen-specific CD4+ T cells.

Authors:  Krzysztof Trzciński; Claudette M Thompson; Amit Srivastava; Alan Basset; Richard Malley; Marc Lipsitch
Journal:  Infect Immun       Date:  2008-04-07       Impact factor: 3.441

8.  Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease.

Authors:  Mark T Dransfield; Moon H Nahm; Meilan K Han; Sarah Harnden; Gerard J Criner; Fernando J Martinez; Paul D Scanlon; Prescott G Woodruff; George R Washko; John E Connett; Nicholas R Anthonisen; William C Bailey
Journal:  Am J Respir Crit Care Med       Date:  2009-06-25       Impact factor: 21.405

9.  Negative frequency-dependent selection and asymmetrical transformation stabilise multi-strain bacterial population structures.

Authors:  Gabrielle L Harrow; John A Lees; William P Hanage; Marc Lipsitch; Jukka Corander; Caroline Colijn; Nicholas J Croucher
Journal:  ISME J       Date:  2021-01-06       Impact factor: 10.302

10.  Pneumococcal capsular polysaccharide structure predicts serotype prevalence.

Authors:  Daniel M Weinberger; Krzysztof Trzciński; Ying-Jie Lu; Debby Bogaert; Aaron Brandes; James Galagan; Porter W Anderson; Richard Malley; Marc Lipsitch
Journal:  PLoS Pathog       Date:  2009-06-12       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.